Literature DB >> 32807860

A cocktail of antibodies for COVID-19 therapy.

Dean B Matthews1.   

Abstract

Entities:  

Year:  2020        PMID: 32807860      PMCID: PMC7430094          DOI: 10.1038/s41577-020-00431-9

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  1 in total

1.  Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic.

Authors:  Joseph H Lubin; Christine Zardecki; Elliott M Dolan; Changpeng Lu; Zhuofan Shen; Shuchismita Dutta; John D Westbrook; Brian P Hudson; David S Goodsell; Jonathan K Williams; Maria Voigt; Vidur Sarma; Lingjun Xie; Thejasvi Venkatachalam; Steven Arnold; Luz Helena Alfaro Alvarado; Kevin Catalfano; Aaliyah Khan; Erika McCarthy; Sophia Staggers; Brea Tinsley; Alan Trudeau; Jitendra Singh; Lindsey Whitmore; Helen Zheng; Matthew Benedek; Jenna Currier; Mark Dresel; Ashish Duvvuru; Britney Dyszel; Emily Fingar; Elizabeth M Hennen; Michael Kirsch; Ali A Khan; Charlotte Labrie-Cleary; Stephanie Laporte; Evan Lenkeit; Kailey Martin; Marilyn Orellana; Melanie Ortiz-Alvarez de la Campa; Isaac Paredes; Baleigh Wheeler; Allison Rupert; Andrew Sam; Katherine See; Santiago Soto Zapata; Paul A Craig; Bonnie L Hall; Jennifer Jiang; Julia R Koeppe; Stephen A Mills; Michael J Pikaart; Rebecca Roberts; Yana Bromberg; J Steen Hoyer; Siobain Duffy; Jay Tischfield; Francesc X Ruiz; Eddy Arnold; Jean Baum; Jesse Sandberg; Grace Brannigan; Sagar D Khare; Stephen K Burley
Journal:  bioRxiv       Date:  2020-12-07
  1 in total
  6 in total

1.  Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19.

Authors:  Tianchuan Zhu; Yuchen Xiao; Xiaojun Meng; Lantian Tang; Bin Li; Zhaoyan Zhao; Qingqin Tan; Hong Shan; Lei Liu; Xi Huang
Journal:  J Nanobiotechnology       Date:  2021-11-25       Impact factor: 10.435

Review 2.  Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?

Authors:  Xuesong He; Xiao Xue Zeng
Journal:  Drug Des Devel Ther       Date:  2022-03-30       Impact factor: 4.162

Review 3.  SARS-CoV-2 variants, spike mutations and immune escape.

Authors:  William T Harvey; Alessandro M Carabelli; Ben Jackson; Ravindra K Gupta; Emma C Thomson; Ewan M Harrison; Catherine Ludden; Richard Reeve; Andrew Rambaut; Sharon J Peacock; David L Robertson
Journal:  Nat Rev Microbiol       Date:  2021-06-01       Impact factor: 78.297

4.  Optimal preparation of SARS-CoV-2 viral transport medium for culture.

Authors:  Julie McAuley; Claire Fraser; Elena Paraskeva; Elizabeth Trajcevska; Michelle Sait; Nancy Wang; Eric Bert; Damian Purcell; Richard Strugnell
Journal:  Virol J       Date:  2021-03-10       Impact factor: 4.099

5.  An update to "novel therapeutic approaches for treatment of COVID-19".

Authors:  Nikoo Hossein-Khannazer; Bahare Shokoohian; Anastasia Shpichka; Hamid Asadzadeh Aghdaei; Peter Timashev; Massoud Vosough
Journal:  J Mol Med (Berl)       Date:  2021-01-03       Impact factor: 4.599

6.  Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19.

Authors:  Daniele Focosi; Federica Novazzi; Angelo Genoni; Francesco Dentali; Daniela Dalla Gasperina; Andreina Baj; Fabrizio Maggi
Journal:  Emerg Infect Dis       Date:  2021-07-27       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.